Michele Gabree

733 total citations
9 papers, 524 citations indexed

About

Michele Gabree is a scholar working on Oncology, Genetics and Immunology. According to data from OpenAlex, Michele Gabree has authored 9 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Genetics and 3 papers in Immunology. Recurrent topics in Michele Gabree's work include Cutaneous Melanoma Detection and Management (5 papers), BRCA gene mutations in cancer (4 papers) and Immunotherapy and Immune Responses (3 papers). Michele Gabree is often cited by papers focused on Cutaneous Melanoma Detection and Management (5 papers), BRCA gene mutations in cancer (4 papers) and Immunotherapy and Immune Responses (3 papers). Michele Gabree collaborates with scholars based in United States, Greece and China. Michele Gabree's co-authors include Hensin Tsao, Kristen M. Shannon, Yuya Kobayashi, Leif W. Ellisen, Lyn M. Duncan, Meredith Mills, Margaret M. DeAngelis, Allison W. Kurian, Ivana K. Kim and Anne Marie Lane and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and British Journal of Dermatology.

In The Last Decade

Michele Gabree

9 papers receiving 516 citations

Peers

Michele Gabree

GENET

MB

ONCOL

CR

PFM

Åke Borg Sweden

Gunnar B. Hansen Sweden

A T'Ang United States

Carole Tirapo France

Beth Blondin United States

Keri Fair United States

Linda Potter United Kingdom

Roshan Sood United Kingdom

Stefan Filges Sweden

Åke Borg Sweden

Michele Gabree

163 ×0.7

GENET

234 ×1.1

MB

226 ×1.1

ONCOL

153 ×1.0

CR

66 ×0.6

PFM

Citations per year, relative to Michele Gabree Michele Gabree (= 1×) peers Åke Borg

Countries citing papers authored by Michele Gabree

Since Specialization

Citations

This map shows the geographic impact of Michele Gabree's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michele Gabree with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michele Gabree more than expected).

Fields of papers citing papers by Michele Gabree

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michele Gabree. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michele Gabree. The network helps show where Michele Gabree may publish in the future.

Co-authorship network of co-authors of Michele Gabree

This figure shows the co-authorship network connecting the top 25 collaborators of Michele Gabree. A scholar is included among the top collaborators of Michele Gabree based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michele Gabree. Michele Gabree is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Ellisen, Leif W., Allison W. Kurian, Meredith Mills, et al.. (2015). Clinical impact of multi-gene panel testing for hereditary breast and ovarian cancer risk assessment.. Journal of Clinical Oncology. 33(15_suppl). 1513–1513. 1 indexed citations

2.

Desmond, Andrea, Allison W. Kurian, Michele Gabree, et al.. (2015). Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment. JAMA Oncology. 1(7). 943–943. 243 indexed citations

3.

Gabree, Michele, et al.. (2014). Clinical Applications of Melanoma Genetics. Current Treatment Options in Oncology. 15(2). 336–350. 8 indexed citations

4.

Gabree, Michele, et al.. (2013). Melanoma Susceptibility Genes and Risk Assessment. Methods in molecular biology. 1102. 381–393. 27 indexed citations

5.

Gabree, Michele, et al.. (2012). Genetic Testing by Cancer Site. The Cancer Journal. 18(4). 372–380. 6 indexed citations

6.

Kim, Ivana K., Adriano Piris, Michele Gabree, et al.. (2012). Germline BAP1 Inactivation Is Preferentially Associated with Metastatic Ocular Melanoma and Cutaneous-Ocular Melanoma Families. PLoS ONE. 7(4). e35295–e35295. 188 indexed citations

7.

Shannon, Kristen M., et al.. (2011). Which individuals undergoing BRACAnalysis need BART testing?. Cancer Genetics. 204(8). 416–422. 6 indexed citations

8.

Nikolaou, Vasiliki, Xiaojing Kang, Alexander Stratigos, et al.. (2011). Comprehensive mutational analysis of CDKN2A and CDK4 in Greek patients with cutaneous melanoma. British Journal of Dermatology. 165(6). 1219–1222. 27 indexed citations

9.

Udayakumar, Durga, Bisundev Mahato, Michele Gabree, & Hensin Tsao. (2010). Genetic Determinants of Cutaneous Melanoma Predisposition. Seminars in Cutaneous Medicine and Surgery. 29(3). 190–195. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact